{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:23:16Z","timestamp":1787426596654,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004238","name":"Universit\u00e4t Potsdam","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004238","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The metabolic syndrome (MetS) is characterized by having three or more of these risk factors: increased blood glucose (Glc), serum triglycerides (TG), blood pressure (BP), waist circumference (WC), and reduced high-density lipoprotein (HDL). Mobile diagnostics using point-of-care (POC) blood analyzers could help identify individuals at risk. This pilot study assessed reliability and validity of MetS risk factor analysis using POC analyzers in a mobile examination unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty participants (52\u2009\u00b1\u20097y; 170\u2009\u00b1\u200910\u00a0cm; 80\u2009\u00b1\u200919\u00a0kg, m\/f: 21\/29) were included for analysis. The mobile examination unit was equipped with different POC analyzers (Alere, LABGEO, CardioChek for Glc, HDL, TG; Quo-Test-A1C Testkit for HbA1c\u2018). Agreement compared to a reference laboratory (RefLab) was analyzed by Bland-Altman (bias, Limits of Agreement (LoA)), ICC, SEM and McNemar\u2019s test. Test-retest analysis was assessed on two different days (max. two weeks apart) using Spearman\u2019s rho, ICC, test-retest variability (TRV%) and McNemar\u2019s test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Based on the smallest bias and low number of missing values (Glc: -5 [LoA\u2009\u2212\u200925 to 6] mg\/dl; TG: 8 [LoA\u2009\u2212\u200958 to 30] mg\/dl; HDL: -2 [LoA\u2009\u2212\u200914 to 9] mg\/dl), and the highest agreement in MetS diagnosis compared to the results of RefLab, the Alere POC device was chosen. Test-retest reliability (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916) for MetS risk factors and HbA1c measured in the mobile setup ranged from poor to excellent with low TRV (0.9\u20135.8%). Risk factor classification and MetS diagnosis did not differ between measurement days.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A mobile setup using the Alere POC analyzer could be used as a valid mobile screening method for MetS to ensure early detection of risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12875-026-03502-3","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:34:35Z","timestamp":1787128475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the reliability and validity for metabolic syndrome diagnosis using point-of-care analyzers in a mobile setup - a pilot study"],"prefix":"10.1186","volume":"27","author":[{"given":"Sanne","family":"Houtenbos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Schraplau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia-Maria","family":"Wippert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"V\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"16","key":"3502_CR1","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation. 2009;120(16):1640\u20135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circulation"},{"issue":"3","key":"3502_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-0030-1247406","volume":"5","author":"S Schipf","year":"2010","unstructured":"Schipf S, Alte D, V\u00f6lzke H, Friedrich N, Haring R, Lohmann T, et al. Pr\u00e4valenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP). Diabetol und Stoffwechsel. 2010;5(3):161\u20138. https:\/\/doi.org\/10.1055\/s-0030-1247406.","journal-title":"Diabetol und Stoffwechsel"},{"key":"3502_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7150\/ijms.13800","volume":"13","author":"K Srikanthan","year":"2016","unstructured":"Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the West Virginian population. Int J Med Sci. 2016;13:25\u201338. https:\/\/doi.org\/10.7150\/ijms.13800.","journal-title":"Int J Med Sci"},{"key":"3502_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-10-138","volume":"10","author":"K Yamaoka","year":"2012","unstructured":"Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: A systematic review and meta-analysis. BMC Med. 2012;10:1\u201310. https:\/\/doi.org\/10.1186\/1741-7015-10-138.","journal-title":"BMC Med"},{"issue":"1","key":"3502_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12229","volume":"16","author":"S O\u2019Neill","year":"2015","unstructured":"O\u2019Neill S, O\u2019Driscoll L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1\u201312. https:\/\/doi.org\/10.1111\/obr.12229.","journal-title":"Obes Rev"},{"issue":"3","key":"3502_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5223\/PGHN.2020.23.3.189","volume":"23","author":"HH Wang","year":"2020","unstructured":"Wang HH, Lee DK, Liu M, Portincasa P, Wang DQH. Novel insights into the pathogenesis and management of the metabolic syndrome. Pediatr Gastroenterol Hepatol Nutr. 2020;23(3):189\u2013230. https:\/\/doi.org\/10.5223\/PGHN.2020.23.3.189.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"3502_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11071652","volume":"11","author":"J Myers","year":"2019","unstructured":"Myers J, Kokkinos P, Nyelin E. Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients. 2019;11:1\u201318. https:\/\/doi.org\/10.3390\/nu11071652.","journal-title":"Nutrients"},{"issue":"9468","key":"3502_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(05)66378-7.","journal-title":"Lancet"},{"key":"3502_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20:1\u20138. https:\/\/doi.org\/10.1007\/s11906-018-0812-z.","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"3502_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3238\/artzebl.2008.0207","volume":"105","author":"S Moebus","year":"2008","unstructured":"Moebus S, Hanisch J, Bramlage P, L\u00f6sch C, Hauner H, Wasem J, et al. Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany. Dtsch Arztebl. 2008;105(12):207\u201313. https:\/\/doi.org\/10.3238\/artzebl.2008.0207.","journal-title":"Dtsch Arztebl"},{"key":"3502_CR11","doi-asserted-by":"publisher","unstructured":"Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN, et al. Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nat Commun. 2026;17(1):1\u201313 . https:\/\/doi.org\/10.1038\/s41467-025-67268-5.","DOI":"10.1038\/s41467-025-67268-5"},{"key":"3502_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-024-02335-7","volume":"23","author":"KS Chong","year":"2024","unstructured":"Chong KS, Chang YH, Yang CT, Chou CK, Ou H, Kuo S. Longitudinal economic burden of incident complications among metabolic syndrome populations. Cardiovasc Diabetol. 2024;23:1\u201310. https:\/\/doi.org\/10.1186\/s12933-024-02335-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3502_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1177\/193229681100500417","volume":"5","author":"M Stuckey","year":"2011","unstructured":"Stuckey M, Fulkerson R, Read E, Russell-Minda E, Munoz C, Kleinstiver P, et al. Remote monitoring technologies for the prevention of metabolic syndrome: The Diabetes and Technology for Increased Activity (DaTA) study. J Diabetes Sci Technol. 2011;5(4):936\u201344. https:\/\/doi.org\/10.1177\/193229681100500417.","journal-title":"J Diabetes Sci Technol"},{"issue":"05","key":"3502_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.24945\/mvf.05.17.1866-0533.2040","volume":"10","author":"MA Goffrier","year":"2017","unstructured":"Goffrier MA, B LLM, B\u00e4tzing MPH, Dr med J, Holstiege MPHJ. Entwicklung der administrativen Pr\u00e4valenz des Diabetes mellitus von 2009 bis 2015. Monit Versorgungsforschung. 2017;10(05):46\u20139. https:\/\/doi.org\/10.24945\/mvf.05.17.1866-0533.2040.","journal-title":"Monit Versorgungsforschung"},{"issue":"1","key":"3502_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.17886\/RKI-GBE-2017-008","volume":"2","author":"C Heidemann","year":"2017","unstructured":"Heidemann C, Kuhnert RBS. RKI - 12-Monats-Pr\u00e4valenz des bekannten Diabetes mellitus in Deutschland - Fact sheet. J Health Monit. 2017;2(1):48\u201356. https:\/\/doi.org\/10.17886\/RKI-GBE-2017-008.","journal-title":"J Health Monit"},{"issue":"1","key":"3502_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-016-1839-y","volume":"16","author":"U Stentzel","year":"2016","unstructured":"Stentzel U, Piegsa J, Fredrich D, Hoffmann W, Van Den Berg N. Accessibility of general practitioners and selected specialist physicians by car and by public transport in a rural region of Germany. BMC Health Serv Res. 2016;16(1):1\u201310. https:\/\/doi.org\/10.1186\/s12913-016-1839-y.","journal-title":"BMC Health Serv Res"},{"key":"3502_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-017-0696-z","volume":"18","author":"B Kuhn","year":"2017","unstructured":"Kuhn B, Kleij KS, Liersch S, Steinh\u00e4user J, Amelung V. Which strategies might improve local primary healthcare in Germany? An explorative study from a local government point of view. BMC Fam Pract. 2017;18:1\u201312. https:\/\/doi.org\/10.1186\/s12875-017-0696-z.","journal-title":"BMC Fam Pract"},{"key":"3502_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-018-0733-6","volume":"19","author":"L Schr\u00f6der","year":"2018","unstructured":"Schr\u00f6der L, Fl\u00e4gel K, Goetz K, Steinh\u00e4user J. Mobility concepts and access to health care in a rural district in Germany: A mixed methods approach. BMC Fam Pract. 2018;19:1\u201310. https:\/\/doi.org\/10.1186\/s12875-018-0733-6.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"3502_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/jjco\/hyn156","volume":"39","author":"NH Yoon","year":"2009","unstructured":"Yoon NH, Lee HY, Kwak MS, Choi KS, Jun JK, Kim MK, et al. Comparison of satisfaction with cancer screening at mobile van and static sites: National cancer screening program in Korea. Jpn J Clin Oncol. 2009;39(3):169\u201374. https:\/\/doi.org\/10.1093\/jjco\/hyn156.","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"3502_CR20","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2214\/AJR.16.17670","volume":"209","author":"E Stanley","year":"2017","unstructured":"Stanley E, Lewis MC, Irshad A, Ackerman S, Collins H, Pavic D, et al. Effectiveness of a mobile mammography program. Am J Roentgenol. 2017;209(6):1426\u20139. https:\/\/doi.org\/10.2214\/AJR.16.17670.","journal-title":"Am J Roentgenol"},{"issue":"6","key":"3502_CR21","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1016\/j.dsx.2019.11.008","volume":"13","author":"HS Gopalan","year":"2019","unstructured":"Gopalan HS, Haque I, Ahmad S, Gaur A, Misra A. Diabetes care at doorsteps: A customised mobile van for the prevention, screening, detection and management of diabetes in the urban underprivileged populations of Delhi. Diabetes Metabolic Syndrome: Clin Res Reviews. 2019;13(6):3105-12. https:\/\/doi.org\/10.1016\/j.dsx.2019.11.008.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"issue":"6","key":"3502_CR22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.trac.2011.01.019","volume":"30","author":"PB Luppa","year":"2011","unstructured":"Luppa PB, M\u00fcller C, Schlichtiger A, Schlebusch H. Point-of-care testing (POCT): Current techniques and future perspectives. TRAC Trends Anal Chem. 2011;30(6):887\u201398. https:\/\/doi.org\/10.1016\/j.trac.2011.01.019.","journal-title":"TRAC Trends Anal Chem"},{"issue":"1","key":"3502_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s40814-021-00898-w","volume":"7","author":"A Schraplau","year":"2021","unstructured":"Schraplau A, Block A, H\u00e4usler A, Wippert PM, Rapp MA, V\u00f6ller H, et al. Mobile diagnostics and consultation for the prevention of the metabolic syndrome and its secondary diseases in Brandenburg\u2014study protocol of a regional prospective cohort study: the Mobile Brandenburg Cohort. Pilot Feasibility Stud. 2021;7(1):1-11. https:\/\/doi.org\/10.1186\/s40814-021-00898-w.","journal-title":"Pilot Feasibility Stud"},{"issue":"4","key":"3502_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/BF02895157","volume":"19","author":"RE Lee","year":"1997","unstructured":"Lee RE, McGinnis KA, Sallis JF, Castro CM, Chen AH, Hickmann SA. Active vs. passive methods of recruiting ethnic minority women to a health promotion program. Ann Behav Med. 1997;19(4):378\u201384. https:\/\/doi.org\/10.1007\/BF02895157.","journal-title":"Ann Behav Med"},{"issue":"2","key":"3502_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1515\/cclm-2016-0303","volume":"55","author":"JA Hirst","year":"2017","unstructured":"Hirst JA, McLellan JH, Price CPEE, Feakins BG, Stevens RJ, et al. Performance of point-of-care HbA1c test devices: implications for use in clinical practice \u2013 a systematic review and meta-analysis. Clin Chem Lab Med (CCLM). 2017;55(2):167\u201380. https:\/\/doi.org\/10.1515\/cclm-2016-0303.","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"3502_CR26","doi-asserted-by":"publisher","unstructured":"World Health Organization. Waist Circumference and Waist-Hip Ratio. Report of a WHO Expert Consultation. 2008 Dec. https:\/\/doi.org\/10.1038\/ejcn.2009.139.","DOI":"10.1038\/ejcn.2009.139"},{"issue":"10","key":"3502_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jacc.2015.12.047","volume":"67","author":"SL Driver","year":"2016","unstructured":"Driver SL, Martin SS, Gluckman TJ, Clary JM, Blumenthal RS, Stone NJ. Fasting or Nonfasting Lipid Measurements. J Am Coll Cardiol. 2016;67(10):1227\u201334. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.047.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3502_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pathol.2018.09.062","volume":"51","author":"A Langsted","year":"2019","unstructured":"Langsted A, Nordestgaard BG. Nonfasting versus fasting lipid profile for cardiovascular risk prediction. Pathology. 2019;51(2):131\u201341. https:\/\/doi.org\/10.1016\/j.pathol.2018.09.062.","journal-title":"Pathology"},{"issue":"9","key":"3502_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3346\/jkms.2012.27.9.1057","volume":"27","author":"SH Park","year":"2012","unstructured":"Park SH, Yoon JS, Won KC, Lee HW. Usefulness of glycated hemoglobin as diagnostic criteria for metabolic syndrome. J Korean Med Sci. 2012;27(9):1057\u201361. https:\/\/doi.org\/10.3346\/jkms.2012.27.9.1057.","journal-title":"J Korean Med Sci"},{"key":"3502_CR30","doi-asserted-by":"publisher","unstructured":"Bland JM, AltmanDG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135\u201360. https:\/\/doi.org\/10.1177\/096228029900800204 . PMID:10501650","DOI":"10.1177\/096228029900800204"},{"issue":"2","key":"3502_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155\u201363. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"J Chiropr Med"},{"key":"3502_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/A-1515-8638","volume":"18","author":"E Schleicher","year":"2022","unstructured":"Schleicher E, Gerdes C, Petersmann A, M\u00fcller-Wieland D, M\u00fcller UA, Freckmann G, et al. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021. Der Diabetologe. 2022;18:41\u20138. https:\/\/doi.org\/10.1055\/A-1515-8638.","journal-title":"Der Diabetologe"},{"issue":"5","key":"3502_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1345\/aph.1K688","volume":"42","author":"RA Dale","year":"2008","unstructured":"Dale RA, Jensen LH, Krantz MJ. Comparison of Two Point-of-Care Lipid Analyzers for Use in Global Cardiovascular Risk Assessments. Ann Pharmacother. 2008;42(5):633\u20139. https:\/\/doi.org\/10.1345\/aph.1K688.","journal-title":"Ann Pharmacother"},{"key":"3502_CR34","doi-asserted-by":"publisher","unstructured":"Lim J, Kim H, Koo SH, Kwon GC. Evaluation of the LABGEO PT10 Point-Of\u2010Care Testing Device: Comparison of Analyte Measurements in Capillary Whole Blood and Lithium Heparin Whole Blood Samples With Those in Central Laboratory. J Clin Lab Anal. 2017;31(3):1-11. https:\/\/doi.org\/10.1002\/jcla.22050.","DOI":"10.1002\/jcla.22050"},{"key":"3502_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-018-1108-z","volume":"18","author":"V Spallone","year":"2018","unstructured":"Spallone V. Blood Pressure Variability and Autonomic Dysfunction. Curr Diab Rep. 2018;18:1\u201314. https:\/\/doi.org\/10.1007\/s11892-018-1108-z.","journal-title":"Curr Diab Rep"},{"key":"3502_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/IBPC.S152761","volume":"11","author":"MR Pioli","year":"2018","unstructured":"Pioli MR, Ritter AMV, de Faria AP, Modolo R. White coat syndrome and its variations: differences and clinical impact. Integr Blood Press Control. 2018;11:73\u20139. https:\/\/doi.org\/10.2147\/IBPC.S152761.","journal-title":"Integr Blood Press Control"},{"key":"3502_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/eurheartj\/sul002","volume":"8","author":"JP Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s JP. Abdominal obesity: The most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J Supplement. 2006;8:4\u201312. https:\/\/doi.org\/10.1093\/eurheartj\/sul002.","journal-title":"Eur Heart J Supplement"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-026-03502-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03502-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03502-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:02:42Z","timestamp":1787425362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12875-026-03502-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3502"],"URL":"https:\/\/doi.org\/10.1186\/s12875-026-03502-3","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the University of Potsdam (No. 40\/2016). All participants were informed about the study goal and methods. They were enrolled after their written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"313"}}